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Abstract
Background: Language bias is a form of publication bias and constitutes a serious threat to meta-
analyses. The Cochrane Controlled Trials Register is one attempt to remedy this and now contains
more than 300,000 citations. However we are still unsure if it provides comprehensive coverage,
particularly for non-English trials.
Methods:  We have recently established a comprehensive register of Japanese trials of
psychotropic drugs through extensive personal contacts, electronic searches and handsearches.
We examined two Cochrane psychiatry group registers against this Japanese database.
Results: The Japanese register contained 56 reports of randomized controlled trials (RCTs) of
antidepressants for depression but the Cochrane Depression, Anxiety and Neurosis group register
contained 18, with an overlap of only nine. The Japanese register contained 61 reports of RCTs of
neuroleptics for schizophrenia and the Cochrane Schizophrenia group register contained 36, with
an overlap of only six. Taking account of some duplicate publications, only a quarter to a third of
all relevant Japanese RCTs were retrievable from the Cochrane group registers.
Conclusions: Similar, or worse, yields may be expected with RCTs conducted in other East Asian
countries, and in other fields of medicine. What evidence there is suggests that this situation may
lead to a systematic over estimate of treatment effect.
Background
Publication bias represents an Achilles' heel in meta-anal-
yses. A particular form of publication bias is the so-called
language bias, by which randomised controlled trials
(RCTs) with greater estimates of effect size tend to be pub-
lished in English rather than in the original authors' native
languages [1]. This bias is compounded by Anglophone
databases and journals considerably under representing
the totality of RCTs. For example, more than half of trials
published in a Hungarian journal, identified through a
cover-to-cover hand search, were not reported in
MEDLINE [2]. Electronic searches of non-English databas-
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es may yet not suffice: a mono-lingual English searcher
would be able to identify only 73% of the trials in the
Spanish/Portuguese LILACS [3] and 70% of the German
PSYNDEX [4].
Attempts are underway to remedy this situation. Two no-
table examples are the Medical Editors Trial Amnesty [5]
and the Cochrane Controlled Trials Register (CCTR). The
latter now contains more than 300,000 citations. Despite
these enormous efforts we still are unsure if any database
provides comprehensive coverage, particularly for non-
English trials. We have recently established a comprehen-
sive register of Japanese trials of psychotropic drugs. We
therefore examined how successful the Cochrane psychia-
try groups have been in identifying trials conducted in Ja-
pan and reported in Japanese by comparing the yields of
the groups' specialized registers against this recently creat-
ed "gold standard."
Methods
Three of the authors (TI, AI, SN) have established a com-
prehensive register of Japanese RCTs of psychotropic
drugs. First, we requested all the pharmaceutical compa-
nies marketing a psychotropic drug in Japan (n = 20) to
provide them with the references concerning their RCTs
with Japanese participants. Second, we carefully searched
the on-line bibliographic database, JMEDICINE (Jan
1981–June 2000). This contains reports of medical litera-
ture in Japanese. Thirdly, we also collected references to
RCTs through the "reference search" of the identified re-
ports. Since on-line JMEDICINE is not available before
1980, and even the best electronic search is likely to miss
a considerable proportion of reports of trials, these au-
thors made considerable efforts to hand search psychiatric
and medical journals likely to contain reports of psycho-
tropics trials (n = 35). Abstracts of academic meetings
have not been included; neither have RCTs undertaken in
Japan but published in the English language journals.
We then asked two Cochrane groups in mental health,
namely the Cochrane Schizophrenia Group and the De-
pression, Anxiety and Neurosis Group, to search their spe-
cialized registers for reports of trials possibly conducted in
Japan. We employed two ways to identify such trials. The
first strategy was to use the search term "Japan*" (*is a
wild card). Because we were not sure if all candidates con-
tained a word "Japan*," we employed the second strategy
in which we searched for all the authors' names appearing
in the Japanese register.
Results
The Japanese register contained 56 reports of RCTs of anti-
depressants for depressed people but the CCDAN register
contained 18, with an overlap of only nine. It was possible
to retrieve five more studies as the CCDAN register con-
tained six English language duplicate publications of the
five original Japanese RCTs. The remaining three studies
found in the CCDAN register but not in the Japanese da-
tabase were English reports of RCTs conducted in Japan
but reported only in the English language. Searching the
CCDAN register would therefore have identified a maxi-
mum of only 25% (=14/56, 95%CI: 15 to 38%) of all Jap-
anese reports of relevant RCTs.
The CSG register contained 36 reports of RCTs of neu-
roleptics given to Japanese people with schizophrenia.
The Japanese register contained 61. Of these, only six had
been registered in the CSG register; 13 more studies were
possible to retrieve as the CSG register contained 18 Eng-
lish language duplicate publications of original Japanese
RCTs. The remaining 12 reports found in the CSG register
but not in the Japanese register were reports of RCTs con-
ducted in Japan but published only in the English jour-
nals. Searching the CSG register only would have
identified 19 or only 31% ( = 19/61, 95%CI: 21 to 44%)
of all relevant reports in the Japanese language.
Discussion and conclusion
The comprehensiveness of the collaborative databases is
now deemed all the more important because doubts have
been expressed as to effectiveness of traditional statistical
tools to examine publication bias such as funnel plots [6].
However, searching the Cochrane group registers would
have missed 69% to 75% of all Japanese reports of RCTs
of antidepressants or neuroleptics. These results clearly
demonstrated the limitations of the current Cochrane
group registers, despite their extensive searching (infor-
mation available from the CCDAN and CSG modules in
the Cochrane Library). Similar, or worse, yields may be ex-
pected with RCTs conducted in other East Asian countries
(Korea, China), and in other fields of medicine.
Many systematic reviews, at least in the field of mental
health, are therefore likely to present results grossly under-
estimating research output from Asia. What evidence
there is suggests that this will result in a systematic over es-
timate of effect [1]. Efforts must be expended for non-An-
glophone countries to prepare their own register of RCTs
for all health interventions in humans. The Japanese data-
base of psychiatry trials has now been merged with the
Cochrane group registers.
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